Език: EN EN
← Назад към резултатите
Набира участници Фаза 2 NCT07105488

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Фаза 2 – изследване на ефективността и дозировката
Заболявания: Atopic Dermatitis (AD)

Спонсор: Bluefin Biomedicine, Inc.

Налично на: БГ
Обобщение
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Кой може да участва
Inclusion Criteria: * Are adults (18-75) with a diagnosis of atopic dermatitis for at least one year. * Have moderate to severe disease not adequately controlled by topical treatments. * Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study. Exclusion Criteria: * Have certain infections or other immune conditions. * Recently used medications that could interfere with the study. * Are pregnant or breastfeeding.
Интервенции
BFB759
BIOLOGICAL
Placebo
DRUG
Места на провеждане 55
Канада (7)
Dermatology Research Institute
Calgary , Alberta
Vida Clinical Research
Edmonton , Alberta
Probity Medical Research
Mississauga , Ontario
Centre de Recherche Saint-Louis (Montreal)
Montreal , Quebec
Probity Medical Research
Richmond Hill , Ontario
York Dermatology
Richmond Hill , Ontario
Saskatoon Dermatology Centre
Saskatoon , Saskatchewan
САЩ (48)
Oakland Hills Dermatology
Auburn Hills , Michigan
Optima Research-Boardman
Boardman , Ohio
Skin Care Research
Boca Raton , Florida
MetroBoston Clinical Partners
Brighton , Massachusetts
DBA Dermatology of Seattle & Bellevue -S
Burien , Washington
Apex Clinical Research Center, LLC
Canton , Ohio
DJL Clinical Research
Charlotte , North Carolina
Florida Academic Dermatology Center Res and Edu, LLC
Coral Gables , Florida
Clinical Trials Management - S
Covington , Louisiana
Dermatology Treatment & Research Center
Dallas , Texas
Skin Cancer and Dermatology Institute
Douglasville , Georgia
Southeast Research Specialists, LLC
Douglasville , Georgia
T. Joseph Raoof Md, Inc
Encino , California
Center for Skin Science and Innovation
Fort Lauderdale , Florida
Schweiger Dermatology, PC R.D.
Hackensack , New Jersey
Marvel Clinical Research
Huntington Beach , California
Antelope Valley Clinical Trials
Lancaster , California
JDR Dermatology Research
Las Vegas , Nevada
Probity Medical Research
Los Angeles , California
Gsi Clinical Research
Margate , Florida
Apex Clinical Research Center, LLC
Mayfield Heights , Ohio
Clinical Trials Management, LLC
Metairie , Louisiana
Elias Research Associates
Missoula , Montana
Stride Clinical Research
Missouri City , Texas
International Clinical Research - Tennesee, LLC
Murfreesboro , Tennessee
Bobby Buka, MD (The Dermatology Specialist)
New York , New York
Bobby Buka, MD
New York , New York
Virginia Dermatology & Skin Cancer Center
Norfolk , Virginia
Ziaderm Research LLC
North Miami Beach , Florida
MI Skin Innovations
Northville , Michigan
Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute
Phoenix , Arizona
Skin Cancer and Dermatology Institute
Phoenix , Arizona
UPMC
Pittsburgh , Pennsylvania
The Indiana Clinical Trials Center
Plainfield , Indiana
Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute
Reno , Nevada
Skin Cancer and Dermatology Institute
Reno , Nevada
NorCal Clinical Research
Rocklin , California
Medisearch, LLC
Saint Joseph , Missouri
Progressive Clinical Research
San Antonio , Texas
Stryde Research-Epiphany Dermatology
Southlake , Texas
Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute
Sparks , Nevada
Skin Cancer and Dermatology Institute
Sparks , Nevada
Lenus Research & Medical Group, LLC
Sweetwater , Florida
Clinical Trials Management - S
Tampa , Florida
Equity Medical, LLC
The Bronx , New York
Focus Clinical Research, LLC -S
West Hills , California
Conquest Research LLC
Winter Park , Florida
Vitality Clinical Trials LLC
Woodbury , New York
Технически детайли
Статус
Набира участници
Фаза
Фаза 2
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Максимална възраст
75 Years
Здрави доброволци
Не
Начална дата
15.07.2025
Крайна дата
31.03.2027
Регистрационен номер
NCT07105488
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.